NEETPGAI
BlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pediatrics/Pediatric Respiratory Disorders
    Pediatric Respiratory Disorders
    medium
    smile Pediatrics

    A newborn presented with chest retractions, dyspnea, and lethargy. The pediatrician diagnosed the baby with respiratory distress syndrome. This occurs due to the deficiency of:

    A. Sphingomyelin
    B. Lecithin
    C. Dipalmitoylphosphatidylethanolamine
    D. Dipalmitoyl inositol

    Explanation

    ## Correct Answer: B. Lecithin Respiratory distress syndrome (RDS) in neonates is caused by deficiency of **pulmonary surfactant**, a complex mixture of lipids and proteins that reduces alveolar surface tension and prevents alveolar collapse during expiration. Lecithin (phosphatidylcholine) comprises approximately 50–70% of surfactant by weight and is the primary surface-tension-reducing component. The fetal lungs begin producing surfactant around 24–28 weeks of gestation, with rapid increase after 32–34 weeks. Premature infants (<34 weeks) have insufficient lecithin production, leading to high alveolar surface tension, alveolar collapse (atelectasis), increased work of breathing, and the classic presentation of chest retractions, dyspnea, and lethargy. The lecithin-to-sphingomyelin (L:S) ratio in amniotic fluid is used prenatally to assess fetal lung maturity; an L:S ratio >2:1 indicates adequate surfactant production. In India, RDS remains a leading cause of neonatal mortality, particularly in preterm infants born in resource-limited settings. Management includes antenatal corticosteroids (betamethasone) to accelerate fetal lung maturation and postnatal exogenous surfactant replacement therapy (e.g., poractant alfa, beractant), which has dramatically improved survival rates in tertiary care centers. ## Why the other options are wrong **A. Sphingomyelin** — Sphingomyelin is a component of amniotic fluid used as a reference marker in the lecithin-to-sphingomyelin ratio for assessing fetal lung maturity, but it is NOT the primary deficient component in RDS. Sphingomyelin levels remain relatively constant throughout pregnancy, whereas lecithin rises sharply after 32 weeks. This is a classic NBE trap—students confuse the L:S ratio (a diagnostic tool) with the actual pathophysiology of RDS. **C. Dipalmitoylphosphatidylethanolamine** — Dipalmitoylphosphatidylethanolamine (DPPE) is a minor phospholipid component of surfactant (~5–10%), not the primary surface-tension-reducing agent. While it contributes to surfactant function, deficiency of DPPE alone does not cause RDS. This option exploits students' confusion between the many lipid components of surfactant. **D. Dipalmitoyl inositol** — Dipalmitoyl inositol is not a recognized component of pulmonary surfactant. This is a distractor option designed to confuse students who may conflate surfactant lipids with other phospholipids found in cell membranes. No clinical relevance to RDS pathophysiology. ## High-Yield Facts - **Lecithin (phosphatidylcholine)** comprises 50–70% of surfactant and is the primary surface-tension-reducing lipid; deficiency causes RDS in preterm infants. - **Lecithin-to-sphingomyelin (L:S) ratio >2:1** in amniotic fluid indicates fetal lung maturity and low risk of RDS; ratio <1.5:1 indicates high risk. - **RDS incidence** is inversely proportional to gestational age; ~60% of infants <28 weeks, ~25% at 32–34 weeks, <5% at >37 weeks. - **Antenatal corticosteroids** (betamethasone 12 mg IM × 2 doses, 24 hours apart) accelerate fetal surfactant production and reduce RDS severity by ~50% in India. - **Exogenous surfactant replacement** (poractant alfa, beractant) given within 2 hours of birth reduces mortality and bronchopulmonary dysplasia in preterm infants. - **Surfactant proteins A and D** (SP-A, SP-D) are collectins that enhance innate immunity and surfactant function; deficiency increases infection risk in RDS. ## Mnemonics **LECITHIN = Lung Essential Component In Tiny Infants Helps IN maturity** Lecithin is the key lipid in surfactant; its rise after 32 weeks marks fetal lung maturity. Use this when assessing preterm birth risk and L:S ratio interpretation. **RDS = Reduced Lecithin → Deficient Surfactant** Preterm infants have insufficient lecithin production → high alveolar surface tension → atelectasis → respiratory distress. Helps link pathophysiology to clinical presentation. ## NBE Trap NBE pairs sphingomyelin with lecithin to exploit students' confusion about the L:S ratio—students may incorrectly think sphingomyelin deficiency causes RDS because it appears in the diagnostic ratio. The key discriminator is that sphingomyelin is a *reference marker*, not the deficient component. ## Clinical Pearl In Indian neonatal units, the L:S ratio from amniotic fluid obtained via amniocentesis is routinely used to counsel mothers of preterm labor cases—an L:S >2:1 allows safe delay of delivery or planned preterm birth, while <1.5:1 mandates urgent antenatal steroids and delivery at a tertiary center with surfactant capability. This simple test has saved countless preterm infants in India. _Reference: OP Ghai Essentials of Pediatrics, Ch. 9 (Neonatal Respiratory Disorders); Harrison Principles of Internal Medicine, Ch. 257 (Respiratory Distress Syndrome)_

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pediatrics Questions